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The lateral organization of lipids in cell membranes is
thought to regulate numerous cell processes. Most
studies focus on the coexistence of two fluid phases,
the liquid crystalline (ld) and the liquid-ordered (lo);
the putative presence of gel domains (so) is not
usually taken into account. We show that in phos-
pholipid:sphingolipid:cholesterol mixtures, in which
sphingomyelin (SM) promoted fluid lo domains, dihy-
drosphingomyelin (DHSM) tended to form rigid
domains. Genetic and pharmacological blockade of
the dihydroceramide desaturase (Des1), which re-
placed SM with DHSM in cultured cells, inhibited
cell infection by replication-competent and -deficient
HIV-1. Increased DHSM levels gave rise to more rigid
membranes, resistant to the insertion of the gp41
fusion peptide, thus inhibiting viral-cell membrane
fusion. These results clarify the function of dihydros-
phingolipids in biological membranes and identify
Des1 as a potential target in HIV-1 infection.
INTRODUCTION
Biological membranes show lateral heterogeneity due to the
presence of lipid domains (Mukherjee andMaxfield, 2004), which
is proposed to be central to cell physiology by spatially and
temporally regulating the formation of multimolecular complexes
at the cell surface (Gon˜i et al., 2008). Identification of factors that
regulate phase formation in living cells would thus be relevant in
pathophysiological processes, including cell infection by many
intracellular pathogens (Man˜es et al., 2003).
Two lamellar phases have been classically defined in model
membranes: the gel or solid-ordered (so) and the liquid-crystal-
line or disordered (ld) phase. Saturated and unsaturated phos-
pholipids partition preferentially into the so and ld phases,766 Chemistry & Biology 17, 766–775, July 30, 2010 ª2010 Elsevier Lrespectively. A liquid-ordered (lo) phase has also been described
in the presence of cholesterol (Chol) (Ipsen et al., 1987). In the
lo phase, acyl chains are in a highly ordered conformation but
lateral lipid diffusion is allowed. The so-called lipid rafts, enriched
in sphingomyelin (SM) and Chol, appear to exist in the lo phase
(Edidin, 2003).
A variety of physical techniques applied to liposomes contain-
ing mixtures of SM:PC (phosphatidylcholine) and/or Chol
have shown the coexistence of gel and fluid, gel and lo, and
lo and ld domains (Almeida et al., 1993; Collado et al., 2005).
Coexistence of the three so, lo and ld phases has been visualized
directly in giant unilamellar vesicles (GUV) containing SM:PC:
Chol:Ceramide (Cer) and SM:PC:PE (phosphatidylethanolami-
ne):Chol (Chiantia et al., 2006; de Almeida et al., 2007; Sot
et al., 2008). Segregation of lo- and ld-like domains in themicrom-
eter range is reported for vesicles isolated from the plasma
membrane of cultured mammalian cells (Baumgart et al.,
2007). Fluorescence recovery after photobleaching (FRAP)
studies indicated the coexistence of lo and ld phases in the
plasma membrane of epithelial cells (Meder et al., 2006), sug-
gesting that the same self-organizing principles operate inmodel
and in living cell membranes. Others found a wide spectrum of
lipid domains with different physical properties in the live cell
plasma membrane, suggesting submicroscopic, unstable lo-like
domains on the cell surface (Hancock, 2006; Jacobson et al.,
2007; Kusumi et al., 2004; Sharma et al., 2004).
Study of phase formation in living cells has been hampered by
the diversity of lipid species in the plasma membrane. Biological
studies have shown the segregation of different sphingolipid
species in distinct regions of the plasma membrane of polarized
cells (Brugger et al., 2004; Fujita et al., 2007; Go´mez-Mouto´n
et al., 2001). To add further complexity, cell membranes contain
‘‘unusual’’ sphingolipids, such as dihydrosphingomyelins
(DHSM), whose biophysical properties have not been studied
in detail. Glycosphingolipids and SM are produced from Cer,
which is in turn biosynthesized de novo in four steps from serine
and palmitoyl-CoA (Kolter and Sandhoff, 2006). The final reac-
tion is the introduction of the (E)-4 double bond into the sphinga-
nine backbone by the dihydroceramide desaturases Des1 andtd All rights reserved
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DHSM Inhibits HIV-1 InfectionDes2. Inhibition of Des1 and/or Des2 should lead to an increase
in DHSM while reducing SM levels.
Dihydrosphingolipid levels are not high in cells, except for the
unusual DHSM enrichment in the human lens (Byrdwell et al.,
1994), and in the human immunodeficiency virus (HIV)-1 enve-
lope (Brugger et al., 2006; Lorizate et al., 2009). Biophysical
studies of liposomes showed that DHSM interacts with higher
affinity than acyl-chain-matched SM with Chol and increases
stability and packing of model membranes (Kuikka et al.,
2001); this observation is further confirmed by comparison of
the rate and extent of cholesterol crystallite formation with SM
and DHSM (Epand, 2003). Nonetheless, the relevance of DHSM
in domain formation or membrane fluidity has not been shown
in living cells.
We explored the functional effects of replacing SMwith DHSM
in artificial membranes and in cell plasma membranes. Domain
formation was studied in GUV containing different amounts of
SM and DHSM, in addition to PC, PE, and Chol. SM was re-
placed with DHSM in plasma membrane by cell incubation
with two Des1 inhibitors (Triola et al., 2004). To analyze the
biological relevance of DHSM in live cells, we determined the
effect of Des1 inhibitors on HIV-1 infection of susceptible cells
as a paradigm of a lipid phase-regulated process.
RESULTS
DHSM Rigidifies lo Domains in GUV Formed
By Ternary Mixtures
Studies in artificial membranes support the idea that DHSM-con-
taining liposomes form with Chol more condensed lo domains
than those containing SM (Kuikka et al., 2001; Nyholm et al.,
2003a, 2003b; Ollila and Slotte, 2002). To address the role of
DHSM in biological membranes, we initially studied the general-
ized polarization (GP) of Laurdan in bilayers formed by SM,
DHSM, and Chol. A decrease in Laurdan GP is directly related
to an increase in water access to the interface and an indication
of increased bilayer fluidity (Parasassi et al., 1990). As predicted,
DHSM:Chol bilayers showed higher Laurdan GP values than
those consisting of SM:Chol in the 15C–50C temperature
range (Figure 1A); temperature increase fluidified the bilayer
and GP decreased accordingly. SM replacement with different
amounts of acyl-matched DHSM promoted a dose-dependent
increase in GP values at all temperatures tested (Figure 1A),
indicating rigidification of the bilayer.
GUV composed of PC:PE:Chol and SMor DHSMwere stained
with the fluorescent probes DiI and NBD-Cer. DiI partitions
preferentially in ld domains, whereas the NBD-Cer probe binds
similarly to lo and ld domains, but is excluded from so phases
(Sot et al., 2008). The DiI probe stained PC:PE:SM:Chol and
PC:PE:DHSM:Chol vesicles similarly, indicating that DHSM did
not alter ld phase formation (Figure 1B). Since a change in bilayer
composition could change DiI partitioning into the ld/lo domains
(Bagatolli, 2006), control experiments using the lo phase probe
Laurdan confirmed that DiI specifically stained ld domains in
both lipid mixtures (not shown). In contrast, NBD-Cer stained
PC:PE:DHSM:Chol GUV more weakly compared to PC:PE:SM:
Chol GUV (Figure 1B). This reduction in NBD-Cer staining was
evident in the region from which DiI was excluded. Indeed, the
ratio of NBD-Cer fluorescence intensity in the lo to the ld phasesChemistry & Biology 17,was clearly lower in DHSM-containing GUV (SM-GUV: 1.06 ±
0.16; DHSM-GUV: 0.42 ± 0.13; Figure 1C). This suggests the
presence of so phase domains interspersed in the lo phase of
PC:PE:DHSM:Chol bilayers. Three-dimensional reconstructions
of DHSM-GUV show two main domains, circular in shape,
limiting one ld and one lo macrodomain (see Figure S1 available
online). Circular boundaries are an indication of liquid-liquid
domain coexistence (Bagatolli, 2006). This supports our previous
assertion that there is not a single, macroscopically separated so
domain, but rather a number of so microdomains interspersed
within the lo phase.
The presence of rigid, gel-like domains in bilayers containing
DHSM was further studied using di-4-ANEPPDHQ. Emission
fluorescence of this probe shifts toward red when inserted in ld
and toward green when incorporated in lo environments (Jin
et al., 2006). Confocal analysis of SM-containing GUV showed
regions predominantly in the ld phase (yellow in merge image)
mixed with smaller lo domains (green). In contrast, we observed
substantial unstained areas in DHSM-containing vesicles, sug-
gesting the presence of more rigid domains (Figure 1D). Quanti-
fication of emission spectra showed a notable reduction in the
area below the lo spectrum of DHSM- compared with SM-con-
taining GUV; however, ld spectra were comparable in both
(Figures 1E and 1F). The results suggest that DHSM-induced
so domains are formed essentially at the expense of the lo phase
(Sot et al., 2008).
Differential scanning calorimetry (DSC) data decisively sup-
ported the presence of gel domains in DHSM-containing
bilayers. When a gel phase melts cooperatively into a fluid
domain, a DSC endotherm is observed, whereas lo-ld thermal
transitions are not detected. We found a clear endotherm
extending from 20C to 50C in DHSM- but not in SM-containing
GUV, indicating gel domain melting under these conditions
(Figure 1G). In summary, our results indicate that DHSM in the
bilayer imposes a change from fluid lo to so domains. This is in
agreement with previous observations of a rigidifying effect of
DHSM, although evidence of so domain formation was lacking.
Chemical Inhibition of Des1 Increases DHSM Levels
in lo Domains of Living Cells
Since replacement of only 30% of SM by DHSM induced a clear
change in bilayer rigidity (Figure 1A), we analyzed the effect of
increasing DHSM levels in the plasma membrane of living cells.
Inhibition of Des1, themain enzyme introducing unsaturation into
dihydroceramides (DHCer), seemed an attractive means of
increasing DHSM levels in cultured cells. The compound GT11
effectively inhibits Des1 activity in neurons (Triola et al., 2004).
Toxicity studies in HEK293 cells indicated that 24 hr incubation
with GT11pyr (a hydrophilic derivative of GT11; Figure 2A) at
concentrations %30 mM minimally affected cell growth (Fig-
ure 2B). Cell cycle analyses indicated a dose-dependent
increase in the percentage of GT11pyr-treated cells in the
S-phase peak, with a concomitant decrease in the G2/M peak
(Figure 2C). At the doses tested, GT11pyr did not affect the
subG0/G1 peak compared with controls (Figure 2C). Short incu-
bation (%24 hr) with GT11pyr does not cause cell death,
although it might slow cell cycle progression.
We compared the relative potency of GT11pyr and GT11 in
inhibiting Des1 activity. Lysates of HEK293 cells and TZM-b1,766–775, July 30, 2010 ª2010 Elsevier Ltd All rights reserved 767
Figure 1. DHSM Forms Gel-Like Domains in
GUV
(A) Temperature variation of the GP of Laurdan
embedded in phospholipid bilayers with indicated
lipid compositions. Mean values ± SEM are shown
(n = 3); in some cases, error bars are smaller than
symbol size.
(B) Representative confocal images (equatorial
sections) of PC:PE:SM:Chol and PC:PE:DHSM:
Chol GUV (1:1:1:1, mol ratio) stained with
NBD-Cer (left) and DiI probes (right). Bar = 10 mm.
(C) Ratio of NBD-Cer fluorescence intensity
measured in the DiI dark to bright regions of
SM- and DHSM-GUV as in (B). Mean values ±
SEM (n = 12).
(D) Representative confocal images (equatorial
section) showing di-4-ANEPPDHQ probe distribu-
tion in lo and ld fluid domains of PC:PE:SM:Chol
and PC:PE:DHSM:Chol GUV. Individual channels
and merge images are shown. Bar = 10 mm.
(E and F) Emission spectra from lo and ld domains
of PC:PE:SM:Chol (E) PC:PE:DHSM:Chol (F) GUV,
represented as normalized fluorescence intensity
at the different wavelengths.
(G) DSC thermograms of the quaternary lipid
mixtures (PC:PE:Chol:SM or DHSM, 1:1:1:1 mol
ratio) dispersed in the form ofMLV. The endotherm
observed with the DHSM-MLV corresponds to
a thermotropic phase transition with DH =
0.49 kcal/mol DHSM. See also Figure S1.
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DHSM Inhibits HIV-1 Infectiona CD4- and CCR5-expressing HeLa subclone, were incubated
with different amounts of GT11 and GT11pyr, and Des1 activity
determined by HPLC using DHCerC6NBD as substrate (Mu-
noz-Olaya et al., 2008). GT11 and GT11pyr inhibited Des1
activity in a dose-dependent manner with similar potency
(Figure 2D).
To determine whether Des1 inhibition leads to effective
replacement of SM by DHSM in the cell membrane, we isolated
sphingolipid-enriched detergent-resistant membrane (DRM)
fractions from HEK293 cells, untreated or treated with GT11pyr
for 24 hr, and analyzed lipid composition by ultra performance
liquid chromatography (UPLC) coupled to mass spectrometry,
using C16 SM as a probe (the most abundant SM in this cell
type). Representative chromatograms of vehicle and GT11pyr
(30 mM)-treated cells are shown (Figure 2E). GT11pyr promoted
a dose-dependent decrease in the relative amount of C16 SM,
which paralleled an increase in the amount of DHSM species in
the DRM fraction (Figure 2F). The DHSM/SM ratio reached
a maximum of 0.3 at 30 mM GT11pyr (Figure 2F). We found
comparable variation in the DHSM/SM ratio for C16:0, C24:0,
and C24:1 species after GT11pyr treatment (Table S1). GT11pyr
also increased the amount of DHCer while decreasing Cer levels
in DRM in a dose-dependent manner (Table S2); nevertheless,
Des1 inhibition affected neither glucosylceramide or lactosylcer-
amide levels nor the SM/glycosphingolipid ratio (Figure S2).
These results indicate that GT11pyr-induced inhibition of Des1
causes the partial replacement of SM and Cer by DHSM and768 Chemistry & Biology 17, 766–775, July 30, 2010 ª2010 Elsevier LDHCer in living cells. It should nonetheless be noted that Cer
and DHCer levels are much lower than those for SM and DHSM
in this cell type.
Increased DHSM Levels Inhibit HIV-1 Infection
We used HIV-1 infection as a model to study the consequences
of the increase in cellular DHSM. HIV-1 infection entails sequen-
tial interactions between the viral envelope (Env) gp120 subunit
with CD4 and to obligate coreceptors (usually CCR5 or
CXCR4), which enables refolding of the Env gp41 fusogenic
subunit, followed by viral and cell membrane fusion. Fusion effi-
ciency is controlled by the clustering of CD4-gp120-coreceptor
complexes at the cell surface (Kuhmann et al., 2000) and by
insertion of the fusion peptide into the host cell membrane.
The actin cytoskeleton (Barrero-Villar et al., 2009; Jimenez-
Baranda et al., 2007; Jolly et al., 2004) and host cell membrane
lipid composition are key determinants for efficient infection.
Indeed, cholesterol sequestration or inhibition of sphingolipid
biosynthesis attenuates virus entry into T cells, monocytes,
and cell lines engineered to express HIV-1 receptors (Man˜es
et al., 2000; Hug et al., 2000; Liu et al., 2002; Carter et al., 2009).
To analyze whether decreasing Des1 activity affects HIV-1
infection of target cells, we incubated TZM-b1 cells with subtoxic
doses of GT11pyr (15–30 mM), followed by exposure to equal
amounts of replication-deficient pNL4.3lucR-E viruses (He
et al., 1995) pseudotyped with ADA (R5 strain), NL4.3 (X4 strain),
or vesicular stomatitis virus (VSV)-G (control) envelopes.td All rights reserved
Figure 2. Des1 Inhibition Replaces SM with DHSM in Cell
Membranes
(A) Chemical structure of the GT11 and GT11pyr inhibitors used.
(B) Effect of GT11pyr doses indicated on viable HEK293 cell number deter-
mined by trypan blue exclusion; determinations were performed by triplicate
for each condition (n = 3).
(C) Effect of GT11pyr on cell cycling determined by propidium iodide. A repre-
sentative of three experiments is shown.
(D) GT11 (open symbols) and GT11pyr (solid symbols) inhibition of Des1
activity in whole cell lysates of HEK293 (black) and TMZ-b1 (red) using
DHCer6-NBD as substrate.
(E) Representative chromatograms obtained by selecting the exact masses of
C16-SM [(SM+H)+: 703.5749 amu; chromatograms b, d] and C16-DHSM
[(DHSM+H)+: 705.5911 amu; chromatograms a, c] in data acquired with
UPLC/TOF from lipid extracts of vehicle- (chromatograms a, b) or GT11pyr-
treated cells (chromatograms c, d). Retention times (min) and peak areas are
indicated.
(F) GT11pyr-induced dose-dependent changes in the DHSM/SM ratio calcu-
lated from chromatograms in (B). Data are the mean ± SD of three replicates.
See also Tables S1 and S2, and Figure S2.
Figure 3. Increased DHSM Levels by Des1 Inhibition Reduces HIV-1
Infection
(A) TZM-b1 cells pretreated with indicated GT11pyr doses (24 hr) were
exposed to luciferase (luc)-encoding HIV-1 viruses pseudotyped with R5,
X4, and VSV-G envelopes. Luc activity was recorded to quantify cell infection.
(B) TZM-bl cells were incubated with GT11 (0.1–3 mM) for 24 hr (solid symbols)
or 5 days (open symbols) and then infected with replication-competent
HIV-1NFN-SX viruses. Cells were assayed for luciferase activity 48 hr later.
Values indicate mean ± SEM of a representative experiment. *p % 0.02,
**p% 0.001 unpaired Student’s t test.
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DHSM Inhibits HIV-1 InfectionGT11pyr reduced cell infection by ADA- and NL4.3-pseudo-
typed viruses up to 60%, without affecting entry of VSV-G virions
(Figure 3A). Since VSV-G-pseudotyped viruses effectively in-
fected GT11pyr-treated cells, the inhibitory effect of this
compound is HIV Env-specific and is not due to a cytotoxic
effect. Independent infection experiments using the replica-Chemistry & Biology 17,tion-competent HIV-1NFN-SX strain in TZM-b1 cells treated with
the hydrophobic inhibitor GT11 showed a time- and dose-
dependent inhibitory effect on HIV-1 infection (Figure 3B) at
nontoxic GT11 doses (not shown). The time-dependent inhibi-
tory effect at very low GT11 doses might reflect slow replace-
ment of SM by DHSM at suboptimal inhibitory concentrations
of Des1, although possible ‘‘long-term’’ pleiotropic effects of
the compound cannot be ruled out. These results indicate that
GT11 and GT11pyr specifically inhibit cell infection by X4- and
R5 HIV-1 strains.
To confirm a role for Des1 in HIV-1 infection, we analyzed virus
infectivity in TZM-b1 cells transfected with Des1-specific small
interference (si)RNA. Knockdown of Des1 reduced Des1 protein
levels (Figure 4A) and activity (Figure 4B) without affecting cell
viability (Figure S3); Des1 silencing also increased the DHCer/
Cer ratio (35%–40%) compared with mock- (2%–4%) or mis-
matched siRNA-transfected cells (5%–12%). HIV-1NFN-SX
infection (10 ng p24) in TZM-b1 cells transfected with
Des1-specific siRNA was significantly reduced compared to
mock- or mismatched siRNA-transfected cells (Figure 4C).
Similar inhibition of infection was observed at higher (50 ng)
and lower (2 ng) viral doses (Figure S4). Pharmacological and
genetic interference with Des1 activity thus inhibited HIV-1
infection of target cells.
Increased DHSM Levels Do Not Affect HIV-1 Receptor
Clustering
Previous reports indicate that gp120-induced receptor clus-
tering is sensitive to lipid modulation. Cholesterol depletion pre-
vents gp120 triggering of CD4-coreceptor colocalization (Man˜es
et al., 2000) and decreases CCR5 diffusion (Steffens and Hope,
2004). Cell treatment with acid sphingomyelinase (SMase),
which transforms SM to Cer, also restricts lateral CD4 mobility
(Finnegan et al., 2004, 2007). Ceramides tend to form so domains
in artificial membranes (Cremesti et al., 2002; Megha, 2004);766–775, July 30, 2010 ª2010 Elsevier Ltd All rights reserved 769
Figure 4. Des1 Silencing Inhibits HIV-1 Infection
(A) TZM-bl cells were transfected with vehicle (mock), mismatched, or Des1-
specific siRNA; after 4 days, Des1 protein levels were analyzed in cell extracts
(20 mg/lane). The same membranes were probed with an anti-b-actin antibody
as loading control. A representative experiment is shown (n = 3).
(B) Des1 activity was assayed in total cell extracts of TZM-b1 cells as in (A),
using DHCer6-NBD as substrate.
(C) The same cells as in (A) were pulsed with HIV-1NFN-SX virus (10 ng p24) and
infectivity recorded by luciferase activity; each point represents the mean ±
SEM of four replicates (n = 2). *p % 0.02 unpaired Student’s t test. See also
Figures S3 and S4.
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DHSM Inhibits HIV-1 Infectionsince DHSM also rigidifies lipid bilayers, GT11pyr-induced inhi-
bition of HIV-1 infection might be explained by impaired clus-
tering of viral receptors.
Analysis of the protein composition of the same DRM fractions
in which the maximal DHSM/SM ratio was detected (Figure 2F)
showed no differences in CD4 partitioning between DRM and
soluble fractions in vehicle- and GT11pyr-treated cells (Fig-
ure 5A). Des1 inhibition did not alter the unique partitioning of
either caveolin or the transferrin receptor, used as controls for
DRM-associated and -excluded membrane proteins, respec-
tively (Figure 5A). There were also no differences between
vehicle- and GT11pyr-treated cells in colocalization of CD4
and CXCR4 HIV-1 receptors with ganglioside GM1 (Figure 5B).
We analyzed the effect of GT11pyr on the formation of higher
order molecular complexes between gp120, CD4, and CXCR4.
Receptor overexpression is reported to overcome the lipid-
modulatory effect of gp120-induced CD4 and/or coreceptor
clustering (Finnegan et al., 2007; Viard et al., 2002). To avoid
misleading effects due to receptor overexpression, we used
resting peripheral blood mononuclear cells (PBMCs) in coclus-
tering experiments; assays were carried out at 12C to avoid
receptor internalization. gp120 induced formation of large
CD4- and CXCR4-containing clusters (Figure 5C), which did
not differ in number or size in vehicle- or GT11pyr-treated
PBMCs (Figures 5D and 5E). The results suggest that the
adverse effect of GT11pyr in HIV-1 infection is not a result of
impaired lateral mobility of HIV-1 receptors.
DHSM-Induced Rigidification Inhibits gp41 Insertion
and Fusion
The effect of Des1 inhibitors on HIV-1 infection might alterna-
tively be explained by regulation of gp41-mediated fusion of viral
and cell membranes. Vesicle fusion involves the formation of
nonlamellar intermediates with inverted phase structure770 Chemistry & Biology 17, 766–775, July 30, 2010 ª2010 Elsevier L(Gon˜i and Alonso, 2000); indeed, the gp41 fusion peptide lowers
the hexagonal phase transition temperature (TH) after insertion
in bilayers (Peisajovich et al., 2000), enabling the formation of
inverted-hexagonal structures. DHSM stabilizes the lamellar
phase toward the inverted hexagonal phase, but no more so
than SM (Figure S5); lamellar phase stabilization by DHSM thus
cannot explain any inhibitory effect on HIV-1 fusion.
Lipids could nonetheless impair the interaction between HIV-1
gp41 and the host cell membrane. SM andChol promote surface
aggregation of the gp41 pretransmembrane sequence (LWYIK)
into lo membranes (Saez-Cirion et al., 2002). To study whether
the DHSM-imposed change in physical properties of the bilayer
prevented fusion peptide insertion, we used intervesicular lipid
mixing to quantitate fusion of large unilamellar vesicles (LUV)
induced by the pretransmembrane stretch of gp41 (HIVc).
DHSM in the LUV greatly decreased the extent of HIVc-induced
intervesicular fusion at 25C (Figure 6A); this inhibitory effect was
lost at temperatures that induce melting of so domains (50
C)
(Figures 1F and 6A, inset). The results indicate that gp41 fusion
peptide insertion is impaired in membranes with high DHSM
levels at temperatures at which so domains are present. We
next analyzed gp160-induced cell-cell fusion in GT11-treated
cells. Only HEK293-CD4 target cells were treated with the
compound (24 hr), which was removed before coincubation
with HEK293-gp160 cells. We observed dose-dependent inhibi-
tion of gp160-induced cell-cell fusion in GT11-treated cells
(Figure 6B). Together, these results suggest that blockade of
Des1 activity inhibits HIV-1 infection by decreasing gp41 inser-
tion into the rigidified microdomains formed by the concurrent
increase in DHSM levels.
DISCUSSION
The lateral organization of lipids in the plasma membrane is
proposed to be central to cell physiology and is thought to be
co-opted by many intracellular pathogens for cell infection
(Man˜es et al., 2003). The concept that HIV-1 hijacks lipid
microdomains in the membrane for infection has been studied
extensively (Man˜es et al., 2000; Hug et al., 2000; Liao et al.,
2001; Gallo et al., 2003). Most evidence is based on drastic
cell treatments that, rather than affecting specificmicrodomains,
destroy the general organization of the membrane. Moreover,
these treatments involve the elimination of lipid species, raising
the question whether the inhibition of HIV-1 infection is due to
perturbation of membrane phases or to the requirement for
such lipids for virus entry.
We designed a strategy to define the contribution of microdo-
main physical properties to the HIV-1 infectivity process by
targeting Des1. Des1 inhibition impedes double bond formation
in sphingolipids, thus increasing the presence of otherwise rare
dihydrosphingolipids. This can alter the physical properties of
the bilayer without eliminating sphingolipid species. Our
biophysical studies establish that in lipid bilayers, DHSM induces
formation of gel-like domains interspersed in the lo phase. In
cells, increasing amounts of DHSM, induced by cell treatment
with two Des1 inhibitors or by knock-down of Des1 expression,
correlated with lower cell susceptibility to HIV-1 infection and
Env-mediated cell-cell fusion. We predict that the DHSM
increase in the membrane of Des-1-inhibited cells fosters thetd All rights reserved
Figure 5. GT11pyr Treatment Does Not Affect HIV-1 Receptor Clustering
(A) The same gradient fractions used in Figure 2E were analyzed in immunoblot with the indicated antibodies. The relative abundance of the proteins in DRM
(lane 1) and soluble (lane 5) fractions is indicated. A representative experiment is shown (n = 3).
(B) Colocalization of CD4, CXCR4, and GFP-GPI (all stained in green) after antibody-induced copatching (12C) with the cholera toxin (CTx)-b subunit (red) in
HEK293 cells. Representative merged images are shown (n = 15 for each protein).
(C–E) Antibody induced coclustering of gp120Env IIIB (X4 strain, red) with CD4 (green) and CXCR4 (blue) in PBMCs. Representative cells are shown (C, n = 10).
Images were processed with ImageJ particle analyzer to determine the number (D) and area (E) of the clusters formed. Bar = 5 mm.
Chemistry & Biology
DHSM Inhibits HIV-1 Infectioncreation of rigid microdomains in which insertion of the gp41
fusion peptide is less efficient than in untreated cells; this in
turn impairs viral-host cell membrane fusion and HIV-1 infection
(Figure 7). Although our results in model membranes provide
a mechanistic explanation of the reduced HIV-1 infection
observed in Des1-inhibited cells, whether a DHSM increase
also promotes formation of so-like domains in cells needs further
research.
Although the existence of so phases in pure lipid bilayers has
been known for decades (Luzzati et al., 1968), only recently
has their presence been reported in cell membranes in physio-
logical conditions, particularly in the presence of Cer (Gon˜i
and Alonso, 2009; Taniguchi et al., 2006; Zhang et al., 2009).
We propose that DHSM also gives rise to gel domains in the
presence of other phospholipids and of sterols. Some of our fluo-
rescence spectroscopy data could be interpreted in terms of
formation of bi- or trimolecular complexes, e.g., DHSM/Chol or
DHSM/(Chol)2, which would mix with other lipid molecules
without giving rise to a separate phase. The DSC calorimetric
data can nonetheless originate only from domains with a
minimum critical size, typically a few thousand molecules, able
to produce a cooperative phase transition (Mabrey and Sturte-
vant, 1976). Our DSC data (Figure 1G) can thus be explainedChemistry & Biology 17,only in terms of gel domains coexisting with fluid domains. The
precise composition of these domains cannot be ascertained
at present, but the fact that they are observed in a complex
mixture (PC/PE/SM or DHSM/Chol) that contains the four major
lipids found in cell membranes supports the idea that similar gel
domains can form in Des-1-inhibited cells. That DHSM actually
forms gel domains in membranes, rather than rendering them
uniformly more rigid, is supported by the inhibition of gp41 fusion
peptide insertion in lipid bilayers in the presence of DHSM at
25C but not at 50C, a temperature above the melting point of
the gel domains. The SM and DHSM used here contain mainly
palmitic acid (C16:0). The physical properties of gel phases
formed by natural SM mixtures in cell membranes might be
somewhat different. Saturated C16 to C24 SM, by far the most
abundant in mammals, all have gel-fluid transition temperatures
from 41C–57C (http://www.lipidat.tcd.ie), equal to or above the
transition temperature of egg SM. Mammalian DHSM will thus
form gel domains more easily than the egg derivative.
Although cell treatment with GT11pyr altered the DHSM/SM
ratio in DRM by a maximum of 30% (Figure 2F), this level of
SM:DHSM replacement in GUV was sufficient to modify bilayer
rigidity as detected by GP of Laurdan (Figure 1A). Despite the
physical changes imposed by DHSM, we found no difference766–775, July 30, 2010 ª2010 Elsevier Ltd All rights reserved 771
Figure 7. Proposed Model for the Blockade of HIV-1 Entry by Des1
Inhibition
In untreated cells, in which DHSM levels are low, gp120-induced clustering of
CD4 and the coreceptors enables insertion of the gp41 fusion peptide (FP) into
the cell membrane (left). Des1 inhibition increases DHSM levels, creating rigid
microdomains (red areas) interspersed in the lo phase (orange); gp41 insertion
into DHSM domains is impaired, which attenuates virus entry (right).
Figure 6. gp41 Insertion Is Impaired in DHSM-Rich Membranes
(A) HIVc-induced fusion of PC:PE:Chol:SM or DHSM (1:1:1:1 mol ratio) LUV.
Intervesicular lipid mixing is shown as a function of the peptide-to-lipid ratio
at 25C (solid symbols and line) and 50C (open symbols, dashed lines).
Data points are the increase in NBD fluorescence (% after 30 min) measured
at 530 nm (excitation at 465 nm) with a cutoff filter at 515 nm. Lipid concentra-
tion in all assays was 100 mM.
(B) HEK293-CD4 target cells were pretreated with GT11 at the indicated
concentrations before coculture with gp160IIIB-expressing effector cells.
Cell-cell fusion was quantified by measurement of luc activity in cell lysates.
Values are mean ± SEM of triplicates in one representative experiment
(n = 4). See also Figure S5.
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DHSM Inhibits HIV-1 Infectionin the gp120-induced lateral motility of CD4 andCXCR4 between
vehicle- and GT11pyr-treated cells (Figures 5C–5E). This con-
trasts with reports on sphingomyelinase-treated cells, in which
increased Cer levels reduced CD4 diffusion (Finnegan et al.,
2007). The difference might be due to the far greater rigidifying
effects of Cer compared with those of SM or DHSM (Sot et al.,
2006, 2008). Indeed, our results suggest differences in the way
that Cer and DHSM mix with SM-rich lo domains. Confocal
microscopy of GUV shows that Cer gives rise to micrometer-
size gel domains, whereas DHSM-induced so domains are
much smaller. These latter domains are poorly resolved by fluo-
rescent confocal microscopy (compare Figure 6 in Sot et al.,
2008, and our Figures 1B and 1C), although DSC unequivocally
demonstrates the presence of gel domains in DHSM-containing
samples (Figure 1F). DHSM domains might not affect the
behavior of neighboring lo regions into which HIV-1 receptors
partition. Indeed, Des1 inhibitors had no effect on T cell activa-
tion and chemotaxis (Figure S6), two processes in which lo
domains play a critical role (Man˜es and Viola, 2006).
In summary, our biophysical and biological evidence shows
that DHSM forms lipid domains different from and more rigid
than SM-rich lo phases. DHSM-, Chol-rich domains might exist
in a gel-like form in cell membranes. Inhibition of gp41-mediated
fusion simply by replacing a minor fraction of sphingolipids with
dihydrosphingolipids clearly demonstrates how membrane
phase segregation controls pathophysiological processes in
living cells.
SIGNIFICANCE
The plasma membrane is widely recognized as a heteroge-
neous cell compartment, given the coexistence of several
kinds of lipid microdomains. HIV-1 co-opts the lateral orga-772 Chemistry & Biology 17, 766–775, July 30, 2010 ª2010 Elsevier Lnization of the plasma membrane to accumulate receptors
and lipids in those regions in which host-viral membrane
fusion will occur. This ‘‘intelligent’’ infection strategy used
by HIV-1 can also be its Achilles’ heel, however, as it can
be used to interfere with virus entry into the cell. Here we
explored the consequences of targeting dihydroceramide
desaturase (Des)1 in HIV-1 infection. Des1 inhibition effec-
tively replaced sphingolipids with dihydrosphingolipids in
the membrane of cultured cells and inhibited HIV-1 cell
infection. Dihydrosphingomyelin (DHSM), the most abun-
dant dihydrosphingolipid in our cell lines, induces formation
of rigid gel-like domains interspersed in the liquid-ordered
phase of model membranes. As a consequence of DHSM
accumulation, membrane microdomains are formed with
sufficient rigidity to hinder gp41 fusion peptide insertion.
Despite the membrane rigidity imposed by dihydrosphingo-
lipids, we found no alteration in gp120-induced lateral
motility of CD4 and CXCR4 in Des1-inhibited compared
with vehicle-treated cells. These results suggest that
increased cell membrane DHSM levels do not disrupt
general membrane organization. The physiological implica-
tions of increased DHSM levels in specific cell types, as well
as the use of Des1 inhibitors in therapy, warrant continued
research.
EXPERIMENTAL PROCEDURES
Materials
Egg phosphatidylcholine (PC), egg phosphatidylethanolamine (PE), and
egg diacylglycerol (DAG) were purchased from Lipid Products (South
Nutfield, UK). Egg SM and Chol were from Avanti Polar Lipids (Alabaster, AL).
1,10-Dioctadecyl-3,3,3030-tetramethylindocarbocyanine perchlorate (DiI) and
di-ANEPPDHQ were from Invitrogen (Eugene, OR). The fluorescent probes
N-(7-nitro-benz-2-oxa-1,3-diazol-4-yl)phosphatidylethanolamine (N-NBD-PE)
and N-(lissamine rhodamine B sulfonyl)phosphatidylethanolamine (N-Rh-PE)
were purchased from Avanti Polar Lipids (Birmingham, AL). HIV p24 ELISA
from Innogenetics (Gent, Belgium), rifampicin from Boehringer (Ingelheim,
Germany), Optiprep (NycomedPharma, Oslo, Norway); CellTiter-Glo Lumines-
cent Cell Viability Assay, MTS, BrightGLo Luciferase System and Dual
Luciferase system were from Promega (Madison, WI). The rabbit polyclonal
anti-Des1 antibodywas agift of J.M. Kraveka (Medical University of SouthCar-
olina, Charleston, SC); anti-transferrin receptor (Zymed Laboratories,td All rights reserved
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and anti-caveolin-1 antibodies (both from Santa Cruz Biotechnology, Santa
Cruz, CA). The sequence DKWASLWNWFNITNWLWYIK (HIVc or preTM), rep-
resenting the pretransmembrane stretch of HIV-1 (BH10 isolate) gp41 was
synthesized by solid-phase synthesis using Fmoc chemistry, as C-terminal
carboxamides and purified by HPLC at the Proteomics Unit of the University
Pompeu-Fabra (Barcelona, Spain). Peptide stock solutions were prepared in
dimethylsulfoxide (DMSO) (spectroscopy grade) and concentrations were
determined by the bicinchoninic acid microassay (Pierce, Rockford, IL).Chemical Synthesis
N-(7-nitro-benz-2-oxa-1,3-diazol-4-yl) ceramide (NBD-Cer) was synthesized
in our facilities. DHSM was obtained by hydrogenation of sphingomyelin.
6-[N-(7-nitro-2,1,3-benzoxadiazol-4-yl)amino] hexanoylsphinganine (DHCer
(C6)-NBD) and GT11 were prepared as described (Munoz-Olaya et al., 2008).
GT11pyr was synthesized from the aminodiol. 8-Bromooctanic acid
(11.8 mg, 0.053 mmol) dissolved in dichloromethane (DCM, 2 ml) was added
to a solution of 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (10.2 mg,
0.053 mmol) and N-hydroxybenzotriazole (8.11 mg, 0.053 mmol) in DCM,
and the solution was stirred (25C, 10 min). In parallel, triethylamine (10 ml,
0.072 mmol) was added dropwise at 25C to a solution of the cyclopropenyla-
minodiol (15mg, 0.048mmol) in DCM (2ml). The activated acid was added and
the mixture stirred (25C, 12 hr). The organic layer was then washed with brine
and dried (MgSO4), the solvent evaporated, and the residue were purified by
flash chromatography. Elution with methylene chloride/methanol (40:1) af-
forded the bromoacyl analog of GT11 (20mg, 0.038 mmol) with a yield of 80%.
The GT11 bromoacyl analog (20 mg, 0.038 mmol) was dissolved in toluene
(2 ml) and, after addition of pyridine (2 ml), was heated at 90C with stirring
(2 hr). Solvents were removed under vacuum, and the residue was thoroughly
washed with hexane and diethylether and then dissolved in methanol and
filtered. Evaporation of methanol afforded GT11-pyr (15 mg, 29 mmol, 75%
yield) as a white solid.Dihydroceramide Desaturase Activity
6-[N-(7-nitro-2,1,3-benzoxadiazol-4-yl)amino] hexanoylsphinganine (DHCer-
C6NBD 50 mM in ethanol), alone or with inhibitors, was incubated (3 hr,
37C) with the cells. After cell lysis by hypotonic shock and sonication, the
lysates were diluted with methanol (900 ml) and centrifuged (17,000 g,
3 min). The supernatant was analyzed by HPLC coupled to a fluorescence
detector, using a reversed-phase column eluted with 20% H2O and 80%
acetonitrile, both with a 0.1% of trifluoroacetic acid. Fluorescence emission
was recorded at 530 nm (excitation at 465 nm). A total of 100 ml was injected
and each sample was run for up to 15 min.Lipid phase Studies
The appropriate lipid mixtures in organic solvent contained 0.2 mol % DiI,
0.4 mol % NBD-Cer, or 0.1 mol % Laurdan as needed. Multilamellar (MLV),
large unilamellar (LUV), and giant unilamellar (GUV) vesicles were prepared
as described (Sot et al., 2008). Excitation wavelengths were 430 nm for
NBD-Cer and 561 nm for DiI. Images were collected through two channels
using band-pass filters of 515 ± 15 nm for NBD-Cer and 593 ± 20 nm for DiI.
The generalized polarization (GP) of Laurdan 829 was measured in a SLM-
AMINCO 8100 spectrofluorometer, equipped with thermoregulated cell
holders. The excitation GPEX parameter was calculated according to
GPEX = ðI440  I490Þ=ðI440  I490Þ
where I440 and I490 are the emission intensities obtained at 440 and 490 nm,
respectively, exciting at 360 nm. The final probe/lipid molar ratio was 1/1000.
GUV were stained with di-4-ANEPPDHQ (10 mM) dissolved in buffer, and
images analyzed in an inverted confocal fluorescence microscope with
a high efficiency spectral detector (Leica TCS SP5, Leica Microsystems
CMS GmbH, Mannheim, Germany). The excitation wavelength was 488 nm.
Images were collected simultaneously in the 500–550 and 650–730 nm chan-
nels and analyzed using the LASAF software (LeicaMicrosystems). Differential
scanning calorimetry (DSC) measurements were performed on MLV as
described (Sot et al., 2008).Chemistry & Biology 17,Cell lines and Cytotoxic Assays
Human embryonic kidney (HEK)-293, HEK293CD4 (a subclone stably express-
ing CD4 receptor), and TZM-b1 cells were cultured as described (Man˜es et al.,
2000). Cell viability after 24 hr incubation with GT11 (not shown) or GT11pyr
was assessed by trypan blue staining and MTS and compared with vehicle-
treated cells. The cell cycle was analyzed by FACS after propidium iodide
staining.
DRM Isolation
GT11pyr-incubated HEK293CD4 cells (24 hr, 37C) were lysed and DRM
isolated (Man˜es et al., 2000). Five fractions were collected from the top to
the bottom of the gradient, the first corresponding to the DRM fraction. Half
was precipitated with TCA and analyzed by western blot with indicated
antibodies, and half processed for lipid composition analysis, using UPLC
coupled to an orthogonal acceleration time-of-flight mass spectrometer with
an electrospray ionization interface (LCT Premier; Waters, Millford, MA).
Data were acquired using positive ionization mode over a mass range of m/z
50–1500 in W-mode. A scan time of 0.15 s and interscan delay of 0.01 s
were used at a nominal instrument resolution of 11500 (FWHM). Leucine
enkephalin was used as the lock spray calibrant. Accurate masses used for
correction were MH m/z 556.2771 and [M-H] m/z 554.2615. These conditions
preclude the use of two standards flanking the mass spectrometry region of
interest.
Immunofluorescence Analyses
For antibody-induced copatching, HEK293CD4 cells or HEK293 transfected
with GFP-GPI (raft marker) were incubated (30 min, 12C) with a mouse
monoclonal anti-CD4 (HP2.6, Del Real et al., 2002) or anti-CXCR4 (K1046,
Santa Cruz Biotechnology) antibodies, and biotinylated cholera toxin
b-subunit, followed by incubation with appropriate Cy2 secondary antibodies
and Cy3-streptavidin (Jackson ImmunoResearch, West Grove, PA), fixed with
paraformaldehyde (3.7%, 5 min, 4C) and methanol (5 min, 20C), and
analyzed by confocal microscopy. Images were acquired in an Olympus-
F1000 confocal microscope and processed with Image J.
For gp120-induced copatching, PBMCs were sequentially incubated
(30 min, 12C) with recombinant gp120 (T cell line-adapted X4 virus, isolate
IIIB, AIDSResearch andReferenceReagent Program,NIAID, NIH), and a rabbit
polyclonal anti-gp120 raised in our laboratory in combination with FITC-HP2.6,
and biotinylated CXCR4 (FAB172, R&D Systems, Minneapolis, MN) anti-
bodies. Finally, anti-rabbit or streptavidin-Cy5 were added (30 min, 12C),
fixed, and analyzed by confocal microscopy.
Env-Mediated Cell-Cell Fusion Assays
HEK293CD4 cells (and HEK293 cells as negative control) were transfected
with pSCluc containing the firefly luciferase gene under the vaccinia virus
7.5 promoter, and pNull promoterless renilla luciferase plasmids, and then
incubated withGT11C8 (24 hr, 37C). HIV-1envIIIB was introduced into effector
HEK293 cells by infection with a recombinant vaccinia virus (1 hr, 37C); 12 hr
post-infection, effector cells cultured in rifampicin (100 mg/ml) were mixed
(6 hr, 37C) with GT11-treated HEK293CD4 cells (1:2 ratio), and firefly and
renilla activity quantified in cell lysates. Relative light units (RLU) were calcu-
lated as the quotient of firefly and renilla activity values, and were indicative
of effector:target cell fusion.
HIV-1 Infectivity Assays
Single-round infection experiments were performed as described (Del Real
et al., 2002). Replication-deficient HIV-1 viruses were generated by cotrans-
fecting pNL4.3lucR-E- (Dr. N. Landau, AIDS Research and Reference Reagent
Program, NIAID, NIH) and either ADA, NL4.3, or VSVG envelopes in HEK293T
cells. Equal amounts (45 ng of p24) of replication-deficient HIV-1 viruses
(HEK293T cells supernatants at 48 hr post-transfection) were added to
vehicle- or GT11pyr-pretreated TZM-b1 cells (24 hr, 37C); after 48 hr, cell
infection was determined by luciferase activity measurement in cell lysates.
For infection with replication-competent HIV-1NFN-SX virus, TZM-bl cells
(2.5 3 105) seeded in 96-well plates were incubated (200 ml) with GT11
(0.1–8 mM) for 24 hr or 5 days, and virus (10 ng of p24) added 24 hr later. Cells
were assayed for luciferase activity 48 hr later (BrightGLo Luciferase System,
Promega) in a Fluoroskan Ascent FL luminometer. Cell viability was assayed in766–775, July 30, 2010 ª2010 Elsevier Ltd All rights reserved 773
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DHSM Inhibits HIV-1 Infectionparallel with CellTiter-Glo Luminescent Cell Viability Assay (Promega). The
percentage of inhibition was calculated as described (Buzo´n et al., 2008).
For knockdown experiments, TZM-bl cells were transfected with vehicle
(mock), siRNA control (Ambion Silencer siRNA control; 40 nM) or Des1-
specific siRNA (50-CCUUCAAUGU GGGUUAUCAtt-30; 40 nM) using Lipofect-
amine 2000 (Invitrogen); after 4 days, cells were assayed for Des1 levels by
western blot, Des1 activity, or exposed to HIV-1NFN-SX (2, 10, or 50 ng p24)
and infectivity analyzed as above.
Intervesicular Lipid Mixing
Membrane lipid mixing was monitored in a Jobin Yvon Fluoromax-3 spectro-
fluorometer using a resonance energy transfer (RET) assay. The assay is based
on the dilution of N-NBD-PE and N-Rh-PE as described (Saez-Cirion et al.,
2002).SUPPLEMENTAL INFORMATION
Supplemental Information includes six figures and two tables and can be
found with this article online at doi:10.1016/j.chembiol.2010.05.023.
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